Herbal Remedy Alternatives for Allergic Rhinitis

  • Mehmet Emrah Ceylan
  • İhsan Kuzucu
  • Nuray Bayar Muluk


Everyday herbal remedies are proliferating, becoming more significant and more popular. Antioxidant herbal remedies tend to exhibit certain clinical benefits. Certain remedies, such as spirulina, acupoint herbal patching, phototherapy, and butterbur are likely to become even more effective in the future. Although herbal remedies are commonly used for treating allergic rhinitis (AR) in Asia and China, they have not been recognized and recommended by international authorities yet, as these tests have generally not met the requirements of being large enough, double-blinded, randomized, or controlled. The tea remedy is becoming a popular, simple, self-care practice for AR patients in Asia. Japanese green tea, containing the active ingredient methylated catechin, has been suggested to be beneficial to cedar-sensitive AR patients, reducing symptoms and resulting in an improved standard of living as well as lowering peripheral blood eosinophilia. The oil of Nigella sativa (black seed) could reduce the symptoms of allergic diseases such as bronchial asthma, allergic rhinitis, and atopic eczema. The oil of N. sativa blocks the 5-lipoxygenase and cyclooxygenase pathways of arachidonic acid metabolism. The butterbur (Petasites hybridus) root can be used to prepare an extract that is rich in petasins—chemicals thought to possess medicinal properties, probably as a result of their effect on the leukotriene pathway. Tinofend® (Tinospora cordifolia), Spanish needle, Cinnamon bark and acerola, Benifuuki green tea, capsaicin (Capsicum annum), cellulose powder, and allergen-absorbing ointment are other specific herbal agents used in the treatment of AR.


Allergic rhinitis Nigella sativa (black seed) Butterbur (Petasites hybridusTinofend® (Tinospora cordifoliaSpanish needle Cinnamon bark and acerola Benifuuki green tea Capsaicin (Capsicum annumCellulose powder Allergen-absorbing ointment 


  1. 1.
    Zhang W. Complementary and alternative medicine for allergic rhinitis. In: Akdis CA, Hellings P, Agache I, editors. Global atlas of allergic rhinitis and chronic rhinosinusitis: European Academy of Allergy and Clinical Immunology; 2014. p. 228–9.Google Scholar
  2. 2.
    Nikakhlagh S, Rahim F, Aryani FH, Syahpoush A, Brougerdnya MG, Saki N. Herbal treatment of allergic rhinitis: the use of Nigella sativa. Am J Otolaryngol. 2011;32(5):402–7. Scholar
  3. 3.
    Ipci K, Oktemer T, Muluk NB, Şahin E, Altıntoprak N, Bafaqeeh SA, Kurt Y, Mladina R, Šubarić M, Cingi C. Alternative products to treat allergic rhinitis and alternative routes for allergy immunotherapy. Am J Rhinol Allergy. 2016;30(suppl. 1(5)):8–10.CrossRefGoogle Scholar
  4. 4.
    Ali BH, Blunden G. Pharmacological and toxicological properties of Nigella sativa. Phytother Res. 2003;17:299–305.CrossRefGoogle Scholar
  5. 5.
    Buyuközturk S, Gelincik A, Ozseker F, et al. Nigellasativa (blackseed) oil does not affect the T-helper 1 and T-helper 2 type cytokine production from splenic mononuclear cells in allergen sensitized mice. J Ethnopharmacol. 2005;100:295–8.CrossRefGoogle Scholar
  6. 6.
    Boskabady MH, Mohsenpoor N, Takaloo L. Antiasthmatic effect of Nigella sativa in airways of asthmatic patients. Phytomedicine. 2010;17:707–13.CrossRefGoogle Scholar
  7. 7.
    Houghton PJ, Zarka R, de las Heras B, Hoult JR. Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Med. 1995;61:33–6.CrossRefGoogle Scholar
  8. 8.
    Charakravarty N. Inhibition of histamine release from mast cells by nigellone. Ann Allergy. 1993;70:237–42.Google Scholar
  9. 9.
    Ghosheh OA, Houdi AA, Crooks PA. High performance liquid chromatographic analysis of the pharmacologically active quinones and related compounds in the oil of the black seed (Nigella sativa). J Pharm Biomed Anal. 1999;19:757–62.CrossRefGoogle Scholar
  10. 10.
    Kalus U, Pruss A, Bystron J, Jurecka M, Smekalova A, Lichius JJ, Kiesewetter H. Effect of Nigella sativa (black seed) on subjective feeling in patients with allergic diseases. Phytother Res. 2003;17(10):1209–14.CrossRefGoogle Scholar
  11. 11.
    Jager L, Kroegel C. Leukotriene receptor antagonists and bronchial asthma. Arzneimittelforschung. 1998;48:205–11.PubMedGoogle Scholar
  12. 12.
    Isik H, Cevikbas¸ A, Gurer US, et al. Potential adjuvant effects of Nigella sativa seeds to improve specific immunotherapy in allergic rhinitis patients. Med Princ Pract. 2010;19:206–11.CrossRefGoogle Scholar
  13. 13.
    Bielory L.Complementary and alternative therapies for allergic rhinitis and conjunctivitis. In: Corren J, Feldweg AM (editors). Up to date. Last updated: Dec 18, 2014.Google Scholar
  14. 14.
    Jackson CM, Lee DK, Lipworth BJ. The effects of butterbur on the histamine and allergen cutaneous response. Ann Allergy Asthma Immunol. 2004;92:250.CrossRefGoogle Scholar
  15. 15.
    Guo R, Pittler MH, Ernst E. Herbal medicines for the treatment of allergic rhinitis: a systematic review. Ann Allergy Asthma Immunol. 2007;99:483.CrossRefGoogle Scholar
  16. 16.
    Schapowal A, Study Group. Treating intermittent allergic rhinitis: a prospective, randomized, placebo and antihistamine-controlled study of Butterbur extract Ze 339. Phytother Res. 2005;19:530.CrossRefGoogle Scholar
  17. 17.
    Lee DK, Gray RD, Robb FM, et al. A placebo-controlled evaluation of butterbur and fexofenadine on objective and subjective outcomes in perennial allergic rhinitis. Clin Exp Allergy. 2004;34:646.CrossRefGoogle Scholar
  18. 18.
    Schapowal A, Petasites Study Group. Randomised controlled trial of butterbur and cetirizine for treating seasonal allergic rhinitis. BMJ. 2002;324:144.CrossRefGoogle Scholar
  19. 19.
    Badar VA, Thawani VR, Wakode PT, et al. Efficacy of Tinospora cordifolia in allergic rhinitis. J Ethnopharmacol. 2005;96:445.CrossRefGoogle Scholar
  20. 20.
    Corren J, Lemay M, Lin Y, et al. Clinical and biochemical effects of a combination botanical product (ClearGuard) for allergy: a pilot randomized double-blind placebo-controlled trial. Nutr J. 2008;7:20.CrossRefGoogle Scholar
  21. 21.
    Available in the United States as ClearGuard. Accessed 01 Mar 2013.
  22. 22.
    Sano M, Suzuki M, Miyase T, et al. Novel antiallergic catechin derivatives isolated from oolong tea. J Agric Food Chem. 1999;47:1906.CrossRefGoogle Scholar
  23. 23.
    Fujimura Y, Tachibana H, Maeda-Yamamoto M, et al. Antiallergic tea catechin, (−)-epigallocatechin-3-O-(3-O-methyl)-gallate, suppresses FcepsilonRI expression in human basophilic KU812 cells. J Agric Food Chem. 2002;50:5729.CrossRefGoogle Scholar
  24. 24.
    Maeda-Yamamoto M, Inagaki N, Kitaura J, et al. O-methylated catechins from tea leaves inhibit multiple protein kinases in mast cells. J Immunol. 2004;172:4486.CrossRefGoogle Scholar
  25. 25.
    Maeda-Yamamoto M, Ema K, Monobe M, et al. Epicatechin-3-O-(3″-O-methyl)-gallate content in various tea cultivars (Camellia sinensis L.) and its in vitro inhibitory effect on histamine release. J Agric Food Chem. 2012;60:2165.CrossRefGoogle Scholar
  26. 26.
    Masuda S, Maeda-Yamamoto M, Usui S, Fujisawa T. ‘Benifuuki’ green tea containing o-methylated catechin reduces symptoms of Japanese cedar pollinosis: a randomized, double-blind, placebo-controlled trial. Allergol Int. 2014;63:211.CrossRefGoogle Scholar
  27. 27.
    Blom HM, Van Rijswijk JB, Garrelds IM, et al. Intranasal capsaicin is efficacious in non-allergic, non-infectious perennial rhinitis. A placebo-controlled study. Clin Exp Allergy. 1997;27:796.CrossRefGoogle Scholar
  28. 28.
    Bernstein JA, Davis BP, Picard JK, et al. A randomized, double-blind, parallel trial comparing capsaicin nasal spray with placebo in subjects with a significant component of nonallergic rhinitis. Ann Allergy Asthma Immunol. 2011;107:171.CrossRefGoogle Scholar
  29. 29.
    In the United States, a product called Sinus Buster is available without a prescription.Google Scholar
  30. 30.
    One such product available in the US and many other countries is called Nasal Ease.Google Scholar
  31. 31.
    Åberg N, Dahl Å, Benson M. A nasally applied cellulose powder in seasonal allergic rhinitis (SAR) in children and adolescents; reduction of symptoms and relation to pollen load. Pediatr Allergy Immunol. 2011;22:594.CrossRefGoogle Scholar
  32. 32.
    A product called “Pollen Blocker” cream is manufactured by Dr. Theiss Alergol and available on line.Google Scholar
  33. 33.
    Bufe A. A simple advice for the prevention of pollen-induced allergic rhinitis. Int Arch Allergy Immunol. 2000;121:85.CrossRefGoogle Scholar
  34. 34.
    Schwetz S, Olze H, Melchisedech S, et al. Efficacy of pollen blocker cream in the treatment of allergic rhinitis. Arch Otolaryngol Head Neck Surg. 2004;130:979.CrossRefGoogle Scholar
  35. 35.
    Geisthoff UW, Blum A, Rupp-Classen M, Plinkert PK. Lipid-based nose ointment for allergic rhinitis. Otolaryngol Head Neck Surg. 2005;133:754.CrossRefGoogle Scholar
  36. 36.
    Weng Z, Zhang B, Asadi S, et al. Quercetin is more effective than cromolyn in blocking human mast cell cytokine release and inhibits contact dermatitis and photosensitivity in humans. PLoS One. 2012;7:e33805.CrossRefGoogle Scholar
  37. 37.
    Remberg P, Björk L, Hedner T, Sterner O. Characteristics, clinical effect profile and tolerability of a nasal spray preparation of Artemisia abrotanum L. for allergic rhinitis. Phytomedicine. 2004;11:36.CrossRefGoogle Scholar
  38. 38.
    Mittman P. Randomized, double-blind study of freeze-dried Urtica dioica in the treatment of allergic rhinitis. Planta Med. 1990;56:44.CrossRefGoogle Scholar
  39. 39.
    Takano H, Osakabe N, Sanbongi C, et al. Extract of Perilla frutescens enriched for rosmarinic acid, a polyphenolic phytochemical, inhibits seasonal allergic rhinoconjunctivitis in humans. Exp Biol Med (Maywood). 2004;229:247.CrossRefGoogle Scholar
  40. 40.
    Burrow A, Eccles R, Jones AS. The effects of camphor, eucalyptus and menthol vapour on nasal resistance to airflow and nasal sensation. Acta Otolaryngol. 1983;96:157.CrossRefGoogle Scholar
  41. 41.
    Food and Drug Administration. Over-the-counter drugs. Final monograph for OTC nasal decongestant drug products. Fed Regist. 1994;41:38408.Google Scholar
  42. 42.
    Volkner JH. Inhalations of extracts from Gingko biloba in vasomotor rhinitis and in the bronchitic syndrome. Dtsch Med J. 1967;18:527.PubMedGoogle Scholar
  43. 43.
    Russo V, Stella A, Appezzati L, et al. Clinical efficacy of a Ginkgo biloba extract in the topical treatment of allergic conjunctivitis. Eur J Ophthalmol. 2009;19:331.CrossRefGoogle Scholar
  44. 44.
    Abenavoli L, Capasso R, Milic N, Capasso F. Milk thistle in liver diseases: past, present, future. Phytother Res. 2010;24:1423.CrossRefGoogle Scholar
  45. 45.
    Bernstein DI, Bernstein CK, Deng C, et al. Evaluation of the clinical efficacy and safety of grapeseed extract in the treatment of fall seasonal allergic rhinitis: a pilot study. Ann Allergy Asthma Immunol. 2002;88:272.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Mehmet Emrah Ceylan
    • 1
  • İhsan Kuzucu
    • 2
  • Nuray Bayar Muluk
    • 3
  1. 1.Department of OtorhinolaryngologyDavraz Yaşam HospitalIspartaTurkey
  2. 2.Department of OtorhinolaryngologyUniversity of Health Sciences, Ankara Numune Training and Research HospitalAnkaraTurkey
  3. 3.Department of Otorhinolaryngology, Medical FacultyKırıkkale UniversityKırıkkaleTurkey

Personalised recommendations